Insider · CIK 0001899772
David Philip Desharnais
Files at REKR (Rekor Systems, Inc.). First filing -, latest -.
In brief
David Philip Desharnais files SEC Form 4 as CEO at REKR (Rekor Systems, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Philip Desharnais has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | REKR Rekor Systems, Inc. | FTax withholding Common Stock | -5,017 | $1.09 | $5,469 | 983,173 | Mar 19, 2025 |
| Jan 17, 2025 | REKR Rekor Systems, Inc. | FTax withholding Common Stock | -40,971 | $1.60 | $66k | 988,190 | Jan 17, 2025 |
| Nov 26, 2024 | REKR Rekor Systems, Inc. | AGrant or award Common Stock | +666,300 | $0.00 | $0 | 1,029,161 | Nov 29, 2024 |
Questions about David Philip Desharnais
Answered from the filings on this page, as of the latest one.
Is David Philip Desharnais buying or selling?
David Philip Desharnais has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Philip Desharnais's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Philip Desharnais has 0.
Where does David Philip Desharnais file Form 4?
David Philip Desharnais has filed Form 4 at REKR (Rekor Systems, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.